Barbara Parker

Title(s)Recall Hcomp, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    UC San Diego2021Revelle Medal
    American Cancer Society, San Diego2019Lifetime Achievement Award
    UC San Diego2009Attending Physician of the Year
    UC San Diego2007Leonard Tow Humanism Award

    Collapse Overview 
    Collapse Overview
    Research Interests
    My research interests include personalized approaches to cancer screening and prevention, new therapies on genomic profiling and breast cancer survivorship issues. I served as the Medical Director of the WHEL Diet Study. I currently serve as the CALGB/Alliance/ACTION clinical trials UCSD Principal Investigator and serve on the CALGB/Alliance Breast Committee and the CALGB/Alliance Prevention Committee. I serve as site PI and Co-Chair of the Diagnosis and Treatment Clinical Care and Research Group of the California Athena Breast Health Network, co-investigator of studies of life-style modification in breast cancer survivors, and co-investigator of studies involving new agents. My clinical practice is comprised of breast cancer patients.

    Education and Training
    BA - Chemistry - University of North Carolina at Chapel Hill, NC - 1974
    MD - Medicine - Stanford University of Medicine, CA - 1981
    Intern/Resident - Medicine - UC San Diego Department of Medicine, CA - 1982-1984
    Chief Resident - Medicine - UC San Diego Department of Medicine, CA - 1985
    Fellowship - Hematology/Oncology - UC San Diego Department of Medicine, CA - 1987

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Corrigendum: Preventing sleep disruption with bright light therapy during chemotherapy for breast cancer: a phase II randomized controlled trial. Front Neurosci. 2024; 18:1386314. Rissling M, Liu L, Youngstedt SD, Trofimenko V, Natarajan L, Neikrug AB, Jeste N, Parker BA, Ancoli-Israel S. PMID: 39420984; PMCID: PMC11483322.
      View in: PubMed   Mentions:
    2. Relationship of physical activity and cognitive functioning among breast cancer survivors: a cross-sectional analysis. Front Cognit. 2024; 3. Hartman SJ, Zablocki RW, Tam RM, Palmer BW, Parker BA, Sears DD, Ahles TA, Natarajan L. PMID: 39483324; PMCID: PMC11526472.
      View in: PubMed   Mentions:
    3. Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer. Breast Cancer Res. 2024 Mar 13; 26(1):46. Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf Ii GF, Messer K, Jamieson C, Kipps TJ, Parker BA. PMID: 38481291; PMCID: PMC10938766.
      View in: PubMed   Mentions:    Fields:    
    4. A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors. Nat Cancer. 2024 Jul; 5(7):996-1009. Park S, Silva E, Singhal A, Kelly MR, Licon K, Panagiotou I, Fogg C, Fong S, Lee JJY, Zhao X, Bachelder R, Parker BA, Yeung KT, Ideker T. PMID: 38443662; PMCID: PMC11286358.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    5. A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer. Breast Cancer Res. 2024 02 26; 26(1):32. Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf GF, Messer K, Jamieson C, Kipps TJ, Parker BA. PMID: 38408999; PMCID: PMC10895766.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    6. Growth signaling autonomy in circulating tumor cells aids metastatic seeding. PNAS Nexus. 2024 Feb; 3(2):pgae014. Sinha S, Farfel A, Luker KE, Parker BA, Yeung KT, Luker GD, Ghosh P. PMID: 38312224; PMCID: PMC10833458.
      View in: PubMed   Mentions: 3  
    7. Early Ascertainment of Breast Cancer Diagnoses Comparing Self-Reported Questionnaires and Electronic Health Record Data Warehouse: The WISDOM Study. JCO Clin Cancer Inform. 2023 08; 7:e2300019. Leggat-Barr K, Ryu R, Hogarth M, Stover-Fiscalini A, Veer LV', Park HL, Lewis T, Thompson C, Borowsky A, Hiatt RA, LaCroix A, Parker B, Madlensky L, Naeim A, Esserman L. PMID: 37607323.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial. Breast Cancer Res Treat. 2023 Jun; 199(2):281-291. Parker BA, Shatsky RA, Schwab RB, Wallace AM, I-SPY 2 Consortium, Wolf DM, Hirst GL, Brown-Swigart L, Esserman LJ, van 't Veer LJ, Ghia EM, Yau C, Kipps TJ. PMID: 37029329; PMCID: PMC10175386.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer. NPJ Breast Cancer. 2022 Dec 01; 8(1):128. Lang JE, Forero-Torres A, Yee D, Yau C, Wolf D, Park J, Parker BA, Chien AJ, Wallace AM, Murthy R, Albain KS, Ellis ED, Beckwith H, Haley BB, Elias AD, Boughey JC, Yung RL, Isaacs C, Clark AS, Han HS, Nanda R, Khan QJ, Edmiston KK, Stringer-Reasor E, Price E, Joe B, Liu MC, Brown-Swigart L, Petricoin EF, Wulfkuhle JD, Buxton M, Clennell JL, Sanil A, Berry S, Asare SM, Wilson A, Hirst GL, Singhrao R, Asare AL, Matthews JB, Melisko M, Perlmutter J, Rugo HS, Symmans WF, van 't Veer LJ, Hylton NM, DeMichele AM, Berry DA, Esserman LJ. PMID: 36456573; PMCID: PMC9715670.
      View in: PubMed   Mentions: 6  
    10. The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancer. Breast Cancer Res Treat. 2023 Jan; 197(2):319-331. Bardia A, Mayer I, Winer E, Linden HM, Ma CX, Parker BA, Bellet M, Arteaga CL, Cheeti S, Gates M, Chang CW, Fredrickson J, Spoerke JM, Moore HM, Giltnane J, Friedman LS, Chow Maneval E, Chan I, Jhaveri K. PMID: 36401732; PMCID: PMC9823088.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Why It Is Time to Challenge Entrenched Beliefs About Breast Cancer Screening. J Womens Health (Larchmt). 2022 07; 31(7):903-904. Esserman LJ, Parker BA, LaCroix AZ. PMID: 35849752.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. Preventing Sleep Disruption With Bright Light Therapy During Chemotherapy for Breast Cancer: A Phase II Randomized Controlled Trial. Front Neurosci. 2022; 16:815872. Rissling M, Liu L, Youngstedt SD, Trofimenko V, Natarajan L, Neikrug AB, Jeste N, Parker BA, Ancoli-Israel S. PMID: 35356054; PMCID: PMC8959343.
      View in: PubMed   Mentions: 5  
    13. Reductions in sleep quality and circadian activity rhythmicity predict longitudinal changes in objective and subjective cognitive functioning in women treated for breast cancer. Support Care Cancer. 2022 Apr; 30(4):3187-3200. Ancoli-Israel S, Liu L, Natarajan L, Rissling M, Neikrug AB, Youngstedt SD, Mills PJ, Sadler GR, Dimsdale JE, Parker BA, Palmer BW. PMID: 34957532; PMCID: PMC8857013.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    14. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial. JAMA Oncol. 2021 Nov 01; 7(11):1654-1663. Symmans WF, Yau C, Chen YY, Balassanian R, Klein ME, Pusztai L, Nanda R, Parker BA, Datnow B, Krings G, Wei S, Feldman MD, Duan X, Chen B, Sattar H, Khazai L, Zeck JC, Sams S, Mhawech-Fauceglia P, Rendi M, Sahoo S, Ocal IT, Fan F, LeBeau LG, Vinh T, Troxell ML, Chien AJ, Wallace AM, Forero-Torres A, Ellis E, Albain KS, Murthy RK, Boughey JC, Liu MC, Haley BB, Elias AD, Clark AS, Kemmer K, Isaacs C, Lang JE, Han HS, Edmiston K, Viscusi RK, Northfelt DW, Khan QJ, Leyland-Jones B, Venters SJ, Shad S, Matthews JB, Asare SM, Buxton M, Asare AL, Rugo HS, Schwab RB, Helsten T, Hylton NM, van 't Veer L, Perlmutter J, DeMichele AM, Yee D, Berry DA, Esserman LJ. PMID: 34529000; PMCID: PMC8446908.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    15. The WISDOM study: a new approach to screening can and should be tested. Breast Cancer Res Treat. 2021 Oct; 189(3):593-598. Esserman L, Eklund M, Veer LV, Shieh Y, Tice J, Ziv E, Blanco A, Kaplan C, Hiatt R, Fiscalini AS, Yau C, Scheuner M, Naeim A, Wenger N, Lee V, Heditsian D, Brain S, Parker BA, LaCroix AZ, Madlensky L, Hogarth M, Borowsky A, Anton-Culver H, Kaster A, Olopade OI, Sheth D, Garcia A, Lancaster R, Plaza M. PMID: 34529196.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    16. Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry. NPJ Breast Cancer. 2021 Aug 03; 7(1):102. Huilgol YS, Keane H, Shieh Y, Hiatt RA, Tice JA, Madlensky L, Sabacan L, Fiscalini AS, Ziv E, Acerbi I, Che M, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker BA, van 't Veer LJ, Athena Breast Health Network Investigators and Advocate Partners, Esserman LJ. PMID: 34344894; PMCID: PMC8333106.
      View in: PubMed   Mentions: 2  
    17. KRAS-Mutated, Estrogen Receptor-Positive Low-Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery. Oncologist. 2021 04; 26(4):e530-e536. Kato S, McFall T, Takahashi K, Bamel K, Ikeda S, Eskander RN, Plaxe S, Parker B, Stites E, Kurzrock R. PMID: 33528846; PMCID: PMC8018312.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. A randomized trial of physical activity for cognitive functioning in breast cancer survivors: Rationale and study design of I Can! Improving Cognition After Cancer. Contemp Clin Trials. 2021 03; 102:106289. Hartman SJ, Weiner LS, Natarajan L, Sears DD, Palmer BW, Parker B, Ahles T, Irwin ML, Au K. PMID: 33503496; PMCID: PMC8009833.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. Cutaneous intralymphatic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma arising in a patient with multiple rounds of breast implants. J Cutan Pathol. 2021 May; 48(5):659-662. Wang HY, Thorson JA, Hinds BR, Swalchick W, Parker BA, Chong A, Wallace AM, Goodman AM. PMID: 33314229.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Continuous, objective measurement of physical activity during chemotherapy for breast cancer: the Activity in Treatment pilot study. Transl Behav Med. 2020 10 08; 10(4):1031-1038. Nelson SH, Weiner LS, Natarajan L, Parker BA, Patterson RE, Hartman SJ. PMID: 31141593; PMCID: PMC7543083.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    21. Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors. Clin Cancer Res. 2020 06 01; 26(11):2546-2555. Vidula N, Rich TA, Sartor O, Yen J, Hardin A, Nance T, Lilly MB, Nezami MA, Patel SP, Carneiro BA, Fan AC, Brufsky AM, Parker BA, Bridges BB, Agarwal N, Maughan BL, Raymond VM, Fairclough SR, Lanman RB, Bardia A, Cristofanilli M. PMID: 32034076.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    22. Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis. NPJ Breast Cancer. 2019; 5:35. Hasan MK, Widhopf GF, Zhang S, Lam SM, Shen Z, Briggs SP, Parker BA, Kipps TJ. PMID: 31667337; PMCID: PMC6814774.
      View in: PubMed   Mentions: 15  
    23. Mediators of a Physical Activity Intervention on Cognition in Breast Cancer Survivors: Evidence From a Randomized Controlled Trial. JMIR Cancer. 2019 Oct 11; 5(2):e13150. Hartman SJ, Weiner LS, Nelson SH, Natarajan L, Patterson RE, Palmer BW, Parker BA, Sears DD. PMID: 31605514; PMCID: PMC6914286.
      View in: PubMed   Mentions: 14  
    24. Research-based PAM50 signature and long-term breast cancer survival. Breast Cancer Res Treat. 2020 Jan; 179(1):197-206. Pu M, Messer K, Davies SR, Vickery TL, Pittman E, Parker BA, Ellis MJ, Flatt SW, Marinac CR, Nelson SH, Mardis ER, Pierce JP, Natarajan L. PMID: 31542876; PMCID: PMC6985186.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    25. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019 09 10; 37(26):2338-2348. Muss HB, Polley MC, Berry DA, Liu H, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Kartcheske PA, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Sutton LM, Magrinat G, Parker BA, Hart RD, Grenier D, Hurria A, Jatoi A, Norton L, Hudis CA, Winer EP, Carey L. PMID: 31339827; PMCID: PMC6900836.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    26. The effects of weight loss and metformin on cognition among breast cancer survivors: Evidence from the Reach for Health study. Psychooncology. 2019 08; 28(8):1640-1646. Hartman SJ, Nelson SH, Marinac CR, Natarajan L, Parker BA, Patterson RE. PMID: 31140202; PMCID: PMC6791123.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    27. miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL Study. Cancer Epidemiol Biomarkers Prev. 2019 09; 28(9):1525-1533. Natarajan L, Pu M, Davies SR, Vickery TL, Nelson SH, Pittman E, Parker BA, Ellis MJ, Flatt SW, Mardis ER, Marinac CR, Pierce JP, Messer K. PMID: 31186261; PMCID: PMC6726562.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Contraceptive utilization and counseling among breast cancer survivors. J Cancer Surviv. 2019 06; 13(3):438-446. Mody SK, Gorman JR, Oakley LP, Layton T, Parker BA, Panelli D. PMID: 31065953; PMCID: PMC6561485.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies. Mol Cancer Ther. 2019 05; 18(5):1001-1011. Shatsky R, Parker BA, Bui NQ, Helsten T, Schwab RB, Boles SG, Kurzrock R. PMID: 30926636.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    30. Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody. Proc Natl Acad Sci U S A. 2019 01 22; 116(4):1370-1377. Zhang S, Zhang H, Ghia EM, Huang J, Wu L, Zhang J, Lam S, Lei Y, He J, Cui B, Widhopf GF, Yu J, Schwab R, Messer K, Jiang W, Parker BA, Carson DA, Kipps TJ. PMID: 30622177; PMCID: PMC6347692.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    31. The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes. J Natl Cancer Inst. 2018 11 01; 110(11):1239-1247. Patterson RE, Marinac CR, Sears DD, Kerr J, Hartman SJ, Cadmus-Bertram L, Villaseñor A, Flatt SW, Godbole S, Li H, Laughlin GA, Oratowski-Coleman J, Parker BA, Natarajan L. PMID: 29788487; PMCID: PMC6235688.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    32. Authentic practice environments to support undergraduate nursing students' readiness for hospital placements. A new model of practice in an on campus simulated hospital and health service. Nurse Educ Pract. 2018 Nov; 33:47-54. Parker BA, Grech C. PMID: 30241029.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance). J Geriatr Oncol. 2018 05; 9(3):221-227. Gajra A, McCall L, Muss HB, Cohen HJ, Jatoi A, Ballman KV, Partridge AH, Sutton L, Parker BA, Magrinat G, Klepin HD, Lafky JM, Hurria A. PMID: 29602735; PMCID: PMC5967401.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    34. Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patients. Cancer. 2018 03 15; 124(6):1288-1296. Schwaederle M, Krishnamurthy N, Daniels GA, Piccioni DE, Kesari S, Fanta PT, Schwab RB, Patel SP, Parker BA, Kurzrock R. PMID: 29211306; PMCID: PMC5839978.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    35. Orbital fat regeneration following hormonal treatment of metastatic breast carcinoma. Orbit. 2018 Jun; 37(3):187-190. Alameddine RM, Ko AC, Mimura M, Parker BA, Lin JH, Korn BS, Kikkawa DO. PMID: 29072521.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability. Cancer Res. 2017 11 15; 77(22):6313-6320. Bieg-Bourne CC, Millis SZ, Piccioni DE, Fanta PT, Goldberg ME, Chmielecki J, Parker BA, Kurzrock R. PMID: 28939679; PMCID: PMC5690871.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    37. Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study. Cancer. 2018 Jan 01; 124(1):192-202. Hartman SJ, Nelson SH, Myers E, Natarajan L, Sears DD, Palmer BW, Weiner LS, Parker BA, Patterson RE. PMID: 28926676; PMCID: PMC5735009.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    38. Technology- and Phone-Based Weight Loss Intervention: Pilot RCT in Women at Elevated Breast Cancer Risk. Am J Prev Med. 2016 11; 51(5):714-721. Hartman SJ, Nelson SH, Cadmus-Bertram LA, Patterson RE, Parker BA, Pierce JP. PMID: 27593420; PMCID: PMC5502803.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    39. Value, Access, and Cost of Cancer Care Delivery at Academic Cancer Centers. J Natl Compr Canc Netw. 2016 07; 14(7):837-47. Nardi EA, Wolfson JA, Rosen ST, Diasio RB, Gerson SL, Parker BA, Alvarnas JC, Levine HA, Fong Y, Weisenburger DD, Fitzgerald CL, Egan M, Stranford S, Carlson RW, Benz EJ. PMID: 27407124.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    40. Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients. Clin Cancer Res. 2016 Nov 15; 22(22):5497-5505. Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, Patel SP, Harismendy O, Ikeda M, Parker BA, Kurzrock R. PMID: 27185373.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    41. Randomized trial of a phone- and web-based weight loss program for women at elevated breast cancer risk: the HELP study. J Behav Med. 2016 08; 39(4):551-9. Cadmus-Bertram L, Nelson SH, Hartman S, Patterson RE, Parker BA, Pierce JP. PMID: 27012848; PMCID: PMC4945463.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    42. Importance of Smoking Cessation to Reduce Breast Cancer Mortality. J Clin Oncol. 2016 Apr 20; 34(12):1295-6. Parker BA, Pierce JP. PMID: 26951316.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors. Support Care Cancer. 2016 08; 24(8):3285-93. Sedjo RL, Flatt SW, Byers T, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J, Naughton M, Pakiz B, Parker BA, Wyatt H, Rock CL. PMID: 26945570; PMCID: PMC5323258.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    44. Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay. Oncotarget. 2016 Mar 01; 7(9):9707-17. Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, Banks KC, Lanman RB, Talasaz A, Parker BA, Kurzrock R. PMID: 26848768; PMCID: PMC4891078.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCells
    45. Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience. Mol Cancer Ther. 2016 04; 15(4):743-52. Schwaederle M, Parker BA, Schwab RB, Daniels GA, Piccioni DE, Kesari S, Helsten TL, Bazhenova LA, Romero J, Fanta PT, Lippman SM, Kurzrock R. PMID: 26873727.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    46. Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors. Contemp Clin Trials. 2016 Mar; 47:64-71. Patterson RE, Marinac CR, Natarajan L, Hartman SJ, Cadmus-Bertram L, Flatt SW, Li H, Parker B, Oratowski-Coleman J, Villaseñor A, Godbole S, Kerr J. PMID: 26706665; PMCID: PMC4818156.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    47. Use of the Fitbit to Measure Adherence to a Physical Activity Intervention Among Overweight or Obese, Postmenopausal Women: Self-Monitoring Trajectory During 16 Weeks. JMIR Mhealth Uhealth. 2015 Nov 19; 3(4):e96. Cadmus-Bertram L, Marcus BH, Patterson RE, Parker BA, Morey BL. PMID: 26586418; PMCID: PMC4705008.
      View in: PubMed   Mentions: 73     Fields:    
    48. Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors. PLoS One. 2015; 10(11):e0142487. Bao L, Messer K, Schwab R, Harismendy O, Pu M, Crain B, Yost S, Frazer KA, Rana B, Hasteh F, Wallace A, Parker BA. PMID: 26554380; PMCID: PMC4640562.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    49. Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors. Breast Cancer Res Treat. 2015 Nov; 154(2):329-37. Demark-Wahnefried W, Colditz GA, Rock CL, Sedjo RL, Liu J, Wolin KY, Krontiras H, Byers T, Pakiz B, Parker BA, Naughton M, Elias A, Ganz PA, ENERGY Trial Group. PMID: 26518022; PMCID: PMC4654570.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    50. Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology. Oncotarget. 2015 Oct 20; 6(32):32602-9. Patel SP, Schwaederle M, Daniels GA, Fanta PT, Schwab RB, Shimabukuro KA, Kesari S, Piccioni DE, Bazhenova LA, Helsten TL, Lippman SM, Parker BA, Kurzrock R. PMID: 26418953; PMCID: PMC4741715.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    51. Impact of increasing physical activity on cognitive functioning in breast cancer survivors: Rationale and study design of Memory & Motion. Contemp Clin Trials. 2015 Nov; 45(Pt B):371-376. Hartman SJ, Natarajan L, Palmer BW, Parker B, Patterson RE, Sears DD. PMID: 26427563; PMCID: PMC4674350.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    52. Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors. J Clin Oncol. 2015 Oct 01; 33(28):3169-76. Rock CL, Flatt SW, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J, Naughton M, Pakiz B, Parker BA, Sedjo RL, Wyatt H. PMID: 26282657; PMCID: PMC4582146.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    53. A window-of-opportunity biomarker study of etodolac in resectable breast cancer. Cancer Med. 2015 Oct; 4(10):1583-8. Schwab RB, Kato S, Crain B, Pu M, Messer K, Weidner N, Blair SL, Wallace AM, Carson DA, Parker BA. PMID: 26275572; PMCID: PMC4618628.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    54. Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center. J Oncol Pract. 2015 Nov; 11(6):442-9. Parker BA, Schwaederlé M, Scur MD, Boles SG, Helsten T, Subramanian R, Schwab RB, Kurzrock R. PMID: 26243651.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    55. Randomized Trial of a Fitbit-Based Physical Activity Intervention for Women. Am J Prev Med. 2015 Sep; 49(3):414-8. Cadmus-Bertram LA, Marcus BH, Patterson RE, Parker BA, Morey BL. PMID: 26071863; PMCID: PMC4993151.
      View in: PubMed   Mentions: 199     Fields:    Translation:Humans
    56. On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients. Mol Cancer Ther. 2015 Jun; 14(6):1488-94. Schwaederle M, Daniels GA, Piccioni DE, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R. PMID: 25852059.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    57. Undernutrition in older people in Australia. Br J Nurs. 2015 Apr 9-22; 24(7):364, 366-70. Ullrich S, McCutcheon H, Parker B. PMID: 25849231.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer. Clin Cancer Res. 2015 Jul 01; 21(13):2911-5. DeMichele A, Yee D, Berry DA, Albain KS, Benz CC, Boughey J, Buxton M, Chia SK, Chien AJ, Chui SY, Clark A, Edmiston K, Elias AD, Forero-Torres A, Haddad TC, Haley B, Haluska P, Hylton NM, Isaacs C, Kaplan H, Korde L, Leyland-Jones B, Liu MC, Melisko M, Minton SE, Moulder SL, Nanda R, Olopade OI, Paoloni M, Park JW, Parker BA, Perlmutter J, Petricoin EF, Rugo H, Symmans F, Tripathy D, van't Veer LJ, Viscusi RK, Wallace A, Wolf D, Yau C, Esserman LJ. PMID: 25712686; PMCID: PMC4490043.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    59. Cyclin alterations in diverse cancers: Outcome and co-amplification network. Oncotarget. 2015 Feb 20; 6(5):3033-42. Schwaederlé M, Daniels GA, Piccioni DE, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R. PMID: 25596748; PMCID: PMC4413635.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    60. Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer. Cell Cycle. 2015; 14(11):1730-7. Schwaederle M, Daniels GA, Piccioni DE, Kesari S, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R. PMID: 25928476; PMCID: PMC4614790.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics. Cell Cycle. 2015; 14(8):1252-9. Kato S, Schwaederle M, Daniels GA, Piccioni D, Kesari S, Bazhenova L, Shimabukuro K, Parker BA, Fanta P, Kurzrock R. PMID: 25695927; PMCID: PMC4614867.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    62. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study. J Neurooncol. 2014 Sep; 119(2):361-8. Scott BJ, van Vugt VA, Rush T, Brown T, Chen CC, Carter BS, Schwab R, Fanta P, Helsten T, Bazhenova L, Parker B, Pingle S, Saria MG, Brown BD, Piccioni DE, Kesari S. PMID: 24942463.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    63. Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. Oncotarget. 2014 May 15; 5(9):2349-54. Wheler JJ, Parker BA, Lee JJ, Atkins JT, Janku F, Tsimberidou AM, Zinner R, Subbiah V, Fu S, Schwab R, Moulder S, Valero V, Schwaederle M, Yelensky R, Miller VA, Stephens MP, Meric-Bernstam F, Kurzrock R. PMID: 24811890; PMCID: PMC4058010.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    64. Molecular tumor board: the University of California-San Diego Moores Cancer Center experience. Oncologist. 2014 Jun; 19(6):631-6. Schwaederle M, Parker BA, Schwab RB, Fanta PT, Boles SG, Daniels GA, Bazhenova LA, Subramanian R, Coutinho AC, Ojeda-Fournier H, Datnow B, Webster NJ, Lippman SM, Kurzrock R. PMID: 24797821; PMCID: PMC4041669.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    65. Risk of breast cancer recurrence associated with carbohydrate intake and tissue expression of IGFI receptor. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1273-9. Emond JA, Pierce JP, Natarajan L, Gapuz LR, Nguyen J, Parker BA, Varki NM, Patterson RE. PMID: 24755714; PMCID: PMC4082443.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    66. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study. Support Care Cancer. 2014 Sep; 22(9):2535-45. Ancoli-Israel S, Liu L, Rissling M, Natarajan L, Neikrug AB, Palmer BW, Mills PJ, Parker BA, Sadler GR, Maglione J. PMID: 24733634; PMCID: PMC4119484.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    67. HER2 aberrations in cancer: implications for therapy. Cancer Treat Rev. 2014 Jul; 40(6):770-80. Yan M, Parker BA, Schwab R, Kurzrock R. PMID: 24656976.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansAnimalsCells
    68. A comparison of regular consumption of fresh lean pork, beef and chicken on body composition: a randomized cross-over trial. Nutrients. 2014 Feb 14; 6(2):682-96. Murphy KJ, Parker B, Dyer KA, Davis CR, Coates AM, Buckley JD, Howe PR. PMID: 24534884; PMCID: PMC3942727.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    69. Nursing practice in nutritional care: a comparison between a residential aged care setting and a hospital setting. J Adv Nurs. 2014 Aug; 70(8):1845-55. Ullrich S, McCutcheon H, Parker B. PMID: 24446837.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    70. Evaluation of ultra-deep targeted sequencing for personalized breast cancer care. Breast Cancer Res. 2013 Dec 10; 15(6):R115. Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA. PMID: 24326041; PMCID: PMC3978701.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    71. The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care. Breast Cancer Res Treat. 2013 Jul; 140(2):417-25. Elson SL, Hiatt RA, Anton-Culver H, Howell LP, Naeim A, Parker BA, Van't Veer LJ, Hogarth M, Pierce JP, Duwors RJ, Hajopoulos K, Esserman LJ, Athena Breast Health Network. PMID: 23887672.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    72. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10; 31(23):2942-62. Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG, Wade JL, Lippman SM. PMID: 23835710.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    73. Developing safety criteria for introducing new agents into neoadjuvant trials. Clin Cancer Res. 2013 Jun 01; 19(11):2817-23. DeMichele A, Berry DA, Zujewski J, Hunsberger S, Rubinstein L, Tomaszewski JE, Kelloff G, Perlmutter J, Buxton M, Lyandres J, Albain KS, Benz C, Chien AJ, Haluska P, Leyland-Jones B, Liu MC, Munster P, Olopade O, Park JW, Parker BA, Pusztai L, Tripathy D, Rugo H, Yee D, Esserman L. PMID: 23470967; PMCID: PMC4096560.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    74. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese. Clin Breast Cancer. 2013 Jun; 13(3):188-95. Rock CL, Pande C, Flatt SW, Ying C, Pakiz B, Parker BA, Williams K, Bardwell WA, Heath DD, Nichols JF. PMID: 23375717; PMCID: PMC4153749.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    75. Fatigue and Circadian Activity Rhythms in Breast Cancer Patients Before and After Chemotherapy: A Controlled Study. Fatigue. 2013; 1(1-2):12-26. Liu L, Rissling M, Neikrug A, Fiorentino L, Natarajan L, Faierman M, Sadler GR, Dimsdale JE, Mills PJ, Parker BA, Ancoli-Israel S. PMID: 23412418; PMCID: PMC3568994.
      View in: PubMed   Mentions: 23  
    76. Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial. Contemp Clin Trials. 2013 Mar; 34(2):282-95. Rock CL, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J, Naughton M, Pakiz B, Parker BA, Sedjo RL, Wyatt H, Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial Group. PMID: 23266440; PMCID: PMC3593786.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    77. Decreased health-related quality of life in women with breast cancer is associated with poor sleep. Behav Sleep Med. 2013; 11(3):189-206. Liu L, Fiorentino L, Rissling M, Natarajan L, Parker BA, Dimsdale JE, Mills PJ, Sadler GR, Ancoli-Israel S. PMID: 23205513; PMCID: PMC3594390.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    78. Web-based self-monitoring for weight loss among overweight/obese women at increased risk for breast cancer: the HELP pilot study. Psychooncology. 2013 Aug; 22(8):1821-8. Cadmus-Bertram L, Wang JB, Patterson RE, Newman VA, Parker BA, Pierce JP. PMID: 23188655.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    79. Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development. J Clin Oncol. 2012 Dec 20; 30(36):4584-6; author reply 4588-9. Yee D, Haddad T, Albain K, Barker A, Benz C, Boughey J, Buxton M, Chien AJ, DeMichele A, Dilts D, Elias A, Haluska P, Hogarth M, Hu A, Hytlon N, Kaplan HG, Kelloff GG, Khan Q, Lang J, Leyland-Jones B, Liu M, Nanda R, Northfelt D, Olopade OI, Park J, Parker B, Parkinson D, Pearson-White S, Perlmutter J, Pusztai L, Symmans F, Rugo H, Tripathy D, Wallace A, Wholley D, Van't Veer L, Berry DA, Esserman L. PMID: 23169510.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    80. Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy. Qual Life Res. 2013 Aug; 22(6):1239-44. Jeste N, Liu L, Rissling M, Trofimenko V, Natarajan L, Parker BA, Ancoli-Israel S. PMID: 22865153; PMCID: PMC3780416.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    81. Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer. Complement Ther Med. 2012 Oct; 20(5):283-90. Saquib J, Parker BA, Natarajan L, Madlensky L, Saquib N, Patterson RE, Newman VA, Pierce JP. PMID: 22863642; PMCID: PMC3413169.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    82. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens. Nucleic Acids Res. 2012 Aug; 40(14):e107. Yost SE, Smith EN, Schwab RB, Bao L, Jung H, Wang X, Voest E, Pierce JP, Messer K, Parker BA, Harismendy O, Frazer KA. PMID: 22492626; PMCID: PMC3413110.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    83. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun. 2012 Jul; 26(5):706-13. Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S. PMID: 22406004; PMCID: PMC3372667.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    84. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep. 2012 Feb 01; 35(2):237-45. Liu L, Rissling M, Natarajan L, Fiorentino L, Mills PJ, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S. PMID: 22294814; PMCID: PMC3250363.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    85. Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med. 2012; 10(3):202-16. Neikrug AB, Rissling M, Trofimenko V, Liu L, Natarajan L, Lawton S, Parker BA, Ancoli-Israel S. PMID: 22742438.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    86. Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer. Support Care Cancer. 2012 Jun; 20(6):1211-9. Ancoli-Israel S, Rissling M, Neikrug A, Trofimenko V, Natarajan L, Parker BA, Lawton S, Desan P, Liu L. PMID: 21660669; PMCID: PMC3192914.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    87. Reclaiming time for nursing practice in nutritional care: outcomes of implementing Protected Mealtimes in a residential aged care setting. J Clin Nurs. 2011 May; 20(9-10):1339-48. Ullrich S, McCutcheon H, Parker B. PMID: 21492280.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    88. IGF1 and risk of additional breast cancer in the WHEL study. Endocr Relat Cancer. 2011 Apr; 18(2):235-44. Al-Delaimy WK, Flatt SW, Natarajan L, Laughlin GA, Rock CL, Gold EB, Caan BJ, Parker BA, Pierce JP. PMID: 21263044.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    89. Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors. Psychooncology. 2011 Mar; 20(3):252-9. Saquib N, Pierce JP, Saquib J, Flatt SW, Natarajan L, Bardwell WA, Patterson RE, Stefanick ML, Thomson CA, Rock CL, Jones LA, Gold EB, Karanja N, Parker BA. PMID: 20878837; PMCID: PMC3297415.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    90. Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):854-8. Caan BJ, Natarajan L, Parker B, Gold EB, Thomson C, Newman V, Rock CL, Pu M, Al-Delaimy W, Pierce JP. PMID: 21357380; PMCID: PMC7359724.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    91. Marine fatty acid intake is associated with breast cancer prognosis. J Nutr. 2011 Feb; 141(2):201-6. Patterson RE, Flatt SW, Newman VA, Natarajan L, Rock CL, Thomson CA, Caan BJ, Parker BA, Pierce JP. PMID: 21178081; PMCID: PMC3021439.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimals
    92. Individual cognitive behavioral therapy for insomnia in breast cancer survivors: a randomized controlled crossover pilot study. Nat Sci Sleep. 2010; 2:1-8. Fiorentino L, McQuaid JR, Liu L, Natarajan L, He F, Cornejo M, Lawton S, Parker BA, Sadler GR, Ancoli-Israel S. PMID: 23616695; PMCID: PMC2953254.
      View in: PubMed   Mentions: 31  
    93. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol. 2011 Jan 01; 29(1):54-60. Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, Laughlin GA, Saquib N, Rock CL, Pierce JP. PMID: 21115861; PMCID: PMC3055860.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    94. Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Res Treat. 2011 Jun; 127(2):541-7. Patterson RE, Saquib N, Natarajan L, Rock CL, Parker BA, Thomson CA, Pierce JP. PMID: 21042931; PMCID: PMC3306248.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    95. Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr. 2011 Jan; 93(1):108-17. Jacobs ET, Thomson CA, Flatt SW, Al-Delaimy WK, Hibler EA, Jones LA, Leroy EC, Newman VA, Parker BA, Rock CL, Pierce JP. PMID: 20980485; PMCID: PMC3001601.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    96. Physical and mental health correlates of pregnancy following breast cancer. Psychooncology. 2010 May; 19(5):517-24. Gorman JR, Roesch SC, Parker BA, Madlensky L, Saquib N, Newman VA, Pierce JP. PMID: 20425779; PMCID: PMC2861788.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    97. Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat. 2010 Aug; 122(3):859-65. Patterson RE, Flatt SW, Saquib N, Rock CL, Caan BJ, Parker BA, Laughlin GA, Erickson K, Thomson CA, Bardwell WA, Hajek RA, Pierce JP. PMID: 20077000; PMCID: PMC2895945.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    98. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 2009 Sep; 32(9):1155-60. Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, Dimsdale JE, Mills PJ, Parker BA, Sadler GR, Ancoli-Israel S. PMID: 19750920; PMCID: PMC2737573.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    99. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009 May 14; 360(20):2055-65. Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP, Kartcheske PA, Wheeler JD, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Magrinat G, Magrinat G, Parker BA, Hart RD, Grenier D, Norton L, Hudis CA, Winer EP, CALGB Investigators. PMID: 19439741; PMCID: PMC3082436.
      View in: PubMed   Mentions: 194     Fields:    Translation:Humans
    100. Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis. J Rheumatol. 2009 May; 36(5):1087-8. Chao J, Parker BA, Zvaifler NJ. PMID: 19435976.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    101. Time-varying effects of prognostic factors associated with disease-free survival in breast cancer. Am J Epidemiol. 2009 Jun 15; 169(12):1463-70. Natarajan L, Pu M, Parker BA, Thomson CA, Caan BJ, Flatt SW, Madlensky L, Hajek RA, Al-Delaimy WK, Saquib N, Gold EB, Pierce JP. PMID: 19403844; PMCID: PMC2733768.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    102. Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women's Healthy Eating and Living Study. Am J Clin Nutr. 2009 May; 89(5):1565S-1571S. Pierce JP, Natarajan L, Caan BJ, Flatt SW, Kealey S, Gold EB, Hajek RA, Newman VA, Rock CL, Pu M, Saquib N, Stefanick ML, Thomson CA, Parker B. PMID: 19339393; PMCID: PMC2677006.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    103. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology. 2009 Feb; 18(2):187-94. Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR, Dimsdale JE, Rissling M, He F, Ancoli-Israel S. PMID: 18677716; PMCID: PMC2762479.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    104. Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol. 2009 Jan 20; 27(3):352-9. Gold EB, Pierce JP, Natarajan L, Stefanick ML, Laughlin GA, Caan BJ, Flatt SW, Emond JA, Saquib N, Madlensky L, Kealey S, Wasserman L, Thomson CA, Rock CL, Parker BA, Karanja N, Jones V, Hajek RA, Pu M, Mortimer JE. PMID: 19075284; PMCID: PMC2645853.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    105. Telephone counseling helps maintain long-term adherence to a high-vegetable dietary pattern. J Nutr. 2007 Oct; 137(10):2291-6. Pierce JP, Newman VA, Natarajan L, Flatt SW, Al-Delaimy WK, Caan BJ, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Kealey S, Madlensky L, Marshall J, Ritenbaugh C, Rock CL, Stefanick ML, Thomson C, Wasserman L, Parker BA. PMID: 17885013; PMCID: PMC2064909.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    106. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. Brain Behav Immun. 2008 Jan; 22(1):98-104. Mills PJ, Ancoli-Israel S, Parker B, Natarajan L, Hong S, Jain S, Sadler GR, von Känel R. PMID: 17706918; PMCID: PMC2199880.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    107. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007 Jul 18; 298(3):289-98. Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, Rock CL, Kealey S, Al-Delaimy WK, Bardwell WA, Carlson RW, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Madlensky L, Marshall J, Newman VA, Ritenbaugh C, Thomson CA, Wasserman L, Stefanick ML. PMID: 17635889; PMCID: PMC2083253.
      View in: PubMed   Mentions: 286     Fields:    Translation:HumansAnimals
    108. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol. 2007 Jun 10; 25(17):2345-51. Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R, Parker BA, Newman VA, Caan B, Rock CL. PMID: 17557947; PMCID: PMC2274898.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansAnimals
    109. Tamoxifen, hot flashes and recurrence in breast cancer. Breast Cancer Res Treat. 2008 Apr; 108(3):421-6. Mortimer JE, Flatt SW, Parker BA, Gold EB, Wasserman L, Natarajan L, Pierce JP, WHEL Study Group. PMID: 17541741; PMCID: PMC2575100.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    110. Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects. Obesity (Silver Spring). 2007 May; 15(5):1179-86. Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Lush CW, Chen K, Lacerte C, Burns C, McKay R, Weyer C, Horowitz M. PMID: 17495194.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    111. Religiosity and preferences for life-prolonging medical treatments in African-American and white elders: a mediation study. Omega (Westport). 2007-2008; 56(3):273-88. Winter L, Dennis MP, Parker B. PMID: 18300651.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    112. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006 Mar; 14(3):201-9. Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, Dimsdale J, Cohen-Zion M, Fiorentino L. PMID: 16010529; PMCID: PMC1599708.
      View in: PubMed   Mentions: 131     Fields:    Translation:Humans
    113. Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and women. Clin Endocrinol (Oxf). 2005 May; 62(5):539-46. Parker BA, Doran S, Wishart J, Horowitz M, Chapman IM. PMID: 15853822.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    114. The relationship between fatigue and light exposure during chemotherapy. Support Care Cancer. 2005 Dec; 13(12):1010-7. Liu L, Marler MR, Parker BA, Jones V, Johnson S, Cohen-Zion M, Fiorentino L, Sadler GR, Ancoli-Israel S. PMID: 15864659; PMCID: PMC1599705.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    115. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol. 2005 Apr; 69(1):85-96. Mills PJ, Parker B, Dimsdale JE, Sadler GR, Ancoli-Israel S. PMID: 15740827.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    116. Relationships of ratings of appetite to food intake in healthy older men and women. Appetite. 2004 Dec; 43(3):227-33. Parker BA, Ludher AK, Loon TK, Horowitz M, Chapman IM. PMID: 15527924.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    117. Food intake and ageing--the role of the gut. Mech Ageing Dev. 2004 Dec; 125(12):859-66. Parker BA, Chapman IM. PMID: 15563931.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    118. Energy intake and appetite are related to antral area in healthy young and older subjects. Am J Clin Nutr. 2004 Sep; 80(3):656-67. Sturm K, Parker B, Wishart J, Feinle-Bisset C, Jones KL, Chapman I, Horowitz M. PMID: 15321806.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    119. The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer. Clin Cancer Res. 2004 Aug 01; 10(15):4998-5003. Mills PJ, Parker B, Jones V, Adler KA, Perez CJ, Johnson S, Cohen-Zion M, Marler M, Sadler GR, Dimsdale JE, Ancoli-Israel S. PMID: 15297400.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    120. Appetite, food intake, and plasma concentrations of cholecystokinin, ghrelin, and other gastrointestinal hormones in undernourished older women and well-nourished young and older women. J Clin Endocrinol Metab. 2003 Aug; 88(8):3747-55. Sturm K, MacIntosh CG, Parker BA, Wishart J, Horowitz M, Chapman IM. PMID: 12915664.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    121. Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care. 2002 Mar; 25(3):425-30. Parker B, Noakes M, Luscombe N, Clifton P. PMID: 11874925.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCTClinical Trials
    122. Making epidemiologic studies responsive to the needs of participants and communities: the Carolina Breast Cancer Study experience. Environ Mol Mutagen. 2002; 39(2-3):96-101. Plummer P, Jackson S, Konarski J, Mahanna E, Dunmore C, Regan G, Mattingly D, Parker B, Williams S, Andrews C, Vannapppagari V, Hall S, Deming S, Hodgson E, Moorman P, Newman B, Millikan R. PMID: 11921175.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    Barbara's Networks
    Concepts (433)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (99)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California